Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial
Maurine D. Miner(Fred Hutch Cancer Center), Anya Luke-Kilolam, Mary Allen(National Institutes of Health), Paul Spearman(Cincinnati Children's Hospital Medical Center), James G. Kublin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Paul T. Edlefsen(Fred Hutch Cancer Center), Allan C. deCamp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Georgia D. Tomaras(National Institutes of Health), Mary E. Enama(National Institutes of Health), Andrew Fioré-Gartland(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nicole Frahm(Fred Hutch Cancer Center), Tamra Madenwald, Jan N. Johannessen, Pei-Chun Yu(Fred Hutch Cancer Center), Ramey Fair, Drienna Holman(Fred Hutch Cancer Center), Lawrence Corey(Fred Hutch Cancer Center), Yevgeny Grigoriev, Bryce Manso(University of California, Santa Cruz), Geneviève Meyer, Ian Frank(Norwegian Womens Public Health Association), Spyros A. Kalams(Vanderbilt University Medical Center), Hyman Scott(UCLA Medical Center), Scharla Estep, M. Juliana McElrath(Fred Hutch Cancer Center), Artur Olhovetchi Kalichman, Renée Holt, Lindsey R. Baden(Brigham and Women's Hospital), Ian Maki(University of Pennsylvania), Richard M. Novak(Northwestern University), Marianne Hansen, Debora Dunbar, Stephen C. De Rosa(University of Washington), Katherine Bar(University of Pennsylvania), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Michael C. Keefer(University of Rochester Medical Center), Hong‐Van Tieu(New York Blood Center), Dave Crawford, Nicole Grunenberg(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa)
Cited by 7
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
|New England Journal of Medicine|1990|1.3k